Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (noted as Standard BioTools Inc. in metadata) on February 12, 2013. The filing serves to announce the company's financial results for the fourth quarter and full year ended December 31, 2012. The detailed financial data is contained in a press release furnished as Exhibit 99.1, which is not included in the provided text.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being reported in the attached press release (Exhibit 99.1) but are not present in the current document.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only confirms that results for the fourth quarter and full year 2012 were issued.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risks, contingencies, or unusual items. The report strictly references the issuance of the press release containing this information.
Investor Verification Checklist
- Verify the specific revenue and net income figures for Q4 and full-year 2012 in the attached Exhibit 99.1 press release.
- Confirm the company's cash position and liquidity status as of December 31, 2012.
- Review the press release for any updated financial guidance or outlook for 2013.
- Check for any material changes in operating expenses or gross margins compared to the prior year.